2025
SJR Q3
JCR Q4 · 0,9
162 matched articles
SCIE
Journal detail
Diagnostic Cytopathology
- Publisher
- John Wiley and Sons Inc
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1097033987551039
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,327
- Quartile Q3
- H-Index 78
- Cites/doc 0,92
- Docs (3y) 491
- Cites (3y) 466
Clarivate
Web of Science · JCR · 2025
- JCR Q Q4
- JIF 0,9
- 5Y JIF 1
- JCI 0,41
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Histology Q3
- Medicine (miscellaneous) Q3
- Pathology and Forensic Medicine Q3
Areas
- Medicine
WoS categories
- Medical Laboratory Technology | Pathology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q4 | 0,327 | 0,9 | 1 | 0,41 | Q4 | 78 |
| 2024 | Q3 | Q4 | 0,377 | 1 | 1,1 | 0,42 | Q3 | 75 |
| 2023 | Q3 | Q4 | 0,411 | 1 | 1,2 | 0,39 | Q4 | 75 |
| 2022 | Q2 | Q4 | 0,433 | 1,3 | 1,2 | 0,42 | Q3 | 75 |
| 2021 | Q3 | Q4 | 0,415 | 1,4 | 1,3 | 0,42 | Q3 | 75 |
| 2020 | Q3 | Q4 | 0,417 | 1,6 | 1,5 | 0,55 | Q3 | 75 |
| 2019 | Q3 | Q3 | 0,441 | 1,2 | 1,2 | 0,53 | Q3 | 75 |
| 2018 | — | Q3 | — | 1,4 | 1,2 | 0,5 | Q3 | — |
| 2017 | Q3 | Q4 | 0,424 | 1 | 1,1 | 0,52 | Q3 | 75 |
| 2016 | Q2 | Q4 | 0,46 | 1,2 | 1,2 | — | — | 75 |
| 2015 | Q2 | Q3 | 0,461 | 1 | 1 | — | — | 75 |
| 2014 | Q2 | Q3 | 0,493 | 1,1 | 1,2 | — | — | 75 |
| 2013 | Q2 | Q3 | 0,612 | 1,5 | 1,5 | — | — | 75 |
| 2012 | Q2 | Q3 | 0,458 | 1,5 | 1,4 | — | — | 75 |
| 2011 | Q2 | Q3 | 0,573 | 1,2 | 1,3 | — | — | 75 |
| 2010 | Q2 | Q3 | 0,551 | 1,3 | 1,3 | — | — | 75 |
| 2009 | — | Q2 | — | 1,3 | 1,2 | — | — | — |
| 2008 | — | Q3 | — | 1,1 | 1,2 | — | — | — |
| 2007 | — | Q3 | — | 1 | 1,1 | — | — | — |
| 2006 | — | Q3 | — | 0,8 | — | — | — | — |
| 2005 | — | Q3 | — | 1 | — | — | — | — |
| 2004 | — | Q3 | — | 1 | — | — | — | — |
| 2003 | — | Q3 | — | 1,1 | — | — | — | — |
| 2002 | — | Q3 | — | 0,9 | — | — | — | — |
| 2001 | — | Q3 | — | 1 | — | — | — | — |
| 2000 | — | Q3 | — | 0,9 | — | — | — | — |
| 1999 | — | Q3 | — | 1 | — | — | — | — |
| 1998 | — | Q2 | — | 0,9 | — | — | — | — |
| 1997 | — | Q2 | — | 1,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q4 | 28/33 |
| 2025 | PATHOLOGY | SCIE | Q4 | Q4 | 76/89 |
| 2024 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q4 | 25/33 |
| 2024 | PATHOLOGY | SCIE | Q4 | Q3 | 71/90 |
| 2023 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q4 | 26/31 |
| 2023 | PATHOLOGY | SCIE | Q4 | Q4 | 70/88 |
| 2022 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q4 | 23/29 |
| 2022 | PATHOLOGY | SCIE | Q4 | Q3 | 60/76 |
| 2021 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q4 | 24/29 |
| 2021 | PATHOLOGY | SCIE | Q4 | Q3 | 63/77 |
| 2020 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q3 | 22/29 |
| 2020 | PATHOLOGY | SCIE | Q4 | Q3 | 61/77 |
| 2019 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | Q3 | 21/29 |
| 2019 | PATHOLOGY | SCIE | Q4 | Q3 | 60/78 |
| 2018 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | Q3 | 21/29 |
| 2018 | PATHOLOGY | SCIE | Q3 | Q3 | 54/76 |
| 2017 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | Q3 | 24/30 |
| 2017 | PATHOLOGY | SCIE | Q4 | Q3 | 67/79 |
| 2016 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q4 | — | 23/30 |
| 2016 | PATHOLOGY | SCIE | Q4 | — | 62/79 |
| 2015 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 22/30 |
| 2015 | PATHOLOGY | SCIE | Q4 | — | 63/79 |
| 2014 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 22/30 |
| 2014 | PATHOLOGY | SCIE | Q4 | — | 62/76 |
| 2013 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 17/31 |
| 2013 | PATHOLOGY | SCIE | Q3 | — | 57/76 |
| 2012 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 17/32 |
| 2012 | PATHOLOGY | SCIE | Q3 | — | 55/77 |
| 2011 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 19/32 |
| 2011 | PATHOLOGY | SCIE | Q4 | — | 61/79 |
| 2010 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 16/31 |
| 2010 | PATHOLOGY | SCIE | Q3 | — | 52/76 |
| 2009 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q2 | — | 13/29 |
| 2009 | PATHOLOGY | SCIE | Q3 | — | 50/71 |
| 2008 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 18/27 |
| 2008 | PATHOLOGY | SCIE | Q4 | — | 54/69 |
| 2007 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 19/26 |
| 2007 | PATHOLOGY | SCIE | Q4 | — | 55/66 |
| 2006 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 18/25 |
| 2006 | PATHOLOGY | SCIE | Q4 | — | 55/64 |
| 2005 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 15/23 |
| 2005 | PATHOLOGY | SCIE | Q4 | — | 50/66 |
| 2004 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 15/24 |
| 2004 | PATHOLOGY | SCIE | Q3 | — | 48/65 |
| 2003 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 17/26 |
| 2003 | PATHOLOGY | SCIE | Q3 | — | 40/64 |
| 2002 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 20/28 |
| 2002 | PATHOLOGY | SCIE | Q3 | — | 47/64 |
| 2001 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 15/24 |
| 2001 | PATHOLOGY | SCIE | Q3 | — | 38/66 |
| 2000 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 15/24 |
| 2000 | PATHOLOGY | SCIE | Q3 | — | 43/67 |
| 1999 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 16/26 |
| 1999 | PATHOLOGY | SCIE | Q3 | — | 35/66 |
| 1998 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 14/26 |
| 1998 | PATHOLOGY | SCIE | Q2 | — | 34/68 |
| 1997 | MEDICAL LABORATORY TECHNOLOGY | SCIE | Q3 | — | 11/21 |
| 1997 | PATHOLOGY | SCIE | Q2 | — | 28/66 |